Safety of Thrombolysis in Stroke Mimics
- 1 April 2013
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 44 (4), 1080-1084
- https://doi.org/10.1161/strokeaha.111.000126
Abstract
Background and Purpose—: Intravenous thrombolysis for acute ischemic stroke is beneficial within 4.5 hours of symptom onset, but the effect rapidly decreases over time, necessitating quick diagnostic in-hospital work-up. Initial time strain occasionally results in treatment of patients with an alternate diagnosis (stroke mimics). We investigated whether intravenous thrombolysis is safe in these patients. Methods—: In this multicenter observational cohort study containing 5581 consecutive patients treated with intravenous thrombolysis, we determined the frequency and the clinical characteristics of stroke mimics. For safety, we compared the symptomatic intracranial hemorrhage (European Cooperative Acute Stroke Study II [ECASS-II] definition) rate of stroke mimics with ischemic strokes. Results—: One hundred stroke mimics were identified, resulting in a frequency of 1.8% (95% confidence interval, 1.5–2.2). Patients with a stroke mimic were younger, more often female, and had fewer risk factors except smoking and previous stroke or transient ischemic attack. The symptomatic intracranial hemorrhage rate in stroke mimics was 1.0% (95% confidence interval, 0.0–5.0) compared with 7.9% (95% confidence interval, 7.2–8.7) in ischemic strokes. Conclusions—: In experienced stroke centers, among patients treated with intravenous thrombolysis, only a few had a final diagnosis other than stroke. The complication rate in these stroke mimics was low.Keywords
This publication has 28 references indexed in Scilit:
- The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trialThe Lancet, 2012
- Stroke Mimics and Intravenous ThrombolysisAnnals of Emergency Medicine, 2012
- How to identify stroke mimics in patients eligible for intravenous thrombolysis?Zeitschrift für Neurologie, 2012
- Safety of Intravenous Thrombolysis within 4.5 h of Symptom Onset in Patients with Negative Post-Treatment Stroke Imaging for Cerebral InfarctionNeurocritical Care, 2011
- Intravenous thrombolytic therapy in patients with stroke mimics: baseline characteristics and safety profileEuropean Journal of Neurology, 2011
- Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trialsThe Lancet, 2010
- Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemiaNeurology, 2010
- Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic StrokeThe New England Journal of Medicine, 2008
- Misdiagnosis of stroke in tissue plasminogen activator–treated patients: Characteristics and outcomesAnnals of Emergency Medicine, 2003
- Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)The Lancet, 1998